Tamoxifen for patients with estrogen receptor-negative breast cancer.

Suppr

超能文献

作者信息

Swain S M

机构信息

National Cancer Institute, Bethesda, MD 20889-5105, USA.

出版信息

J Clin Oncol. 2001 Sep 15;19(18 Suppl):93S-97S.

PMID:11560981

Abstract

摘要

相似文献

Tamoxifen for patients with estrogen receptor-negative breast cancer.

J Clin Oncol. 2001 Sep 15;19(18 Suppl):93S-97S.

The nature of tamoxifen action in the control of female breast cancer.

In Vivo. 2001 Jul-Aug;15(4):319-25.

Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.

J Clin Oncol. 2005 Jul 20;23(21):4687-94. doi: 10.1200/JCO.2005.04.076. Epub 2005 Apr 18.

Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.

Int J Oncol. 2005 Apr;26(4):1025-31.

Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.

J Natl Cancer Inst Monogr. 2006(36):7-15. doi: 10.1093/jncimonographs/lgj003.

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.

Eur J Cancer. 2009 Sep;45(14):2496-502. doi: 10.1016/j.ejca.2009.05.022. Epub 2009 Jun 15.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62. doi: 10.1093/jnci/dji372.

Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.

J Clin Oncol. 2005 Nov 1;23(31):7842-8. doi: 10.1200/JCO.2005.01.3433.

Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

J Clin Oncol. 2006 Mar 20;24(9):1332-41. doi: 10.1200/JCO.2005.03.0783. Epub 2006 Feb 27.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17.

引用本文的文献

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.

Breast Cancer Res. 2018 Jul 11;20(1):74. doi: 10.1186/s13058-018-0996-9.

Pilot Survey of Breast Cancer Management in Sub-Saharan Africa.

J Glob Oncol. 2016 Dec 21;3(3):194-200. doi: 10.1200/JGO.2016.004945. eCollection 2017 Jun.

Protein function in precision medicine: deep understanding with machine learning.

FEBS Lett. 2016 Aug;590(15):2327-41. doi: 10.1002/1873-3468.12307. Epub 2016 Aug 6.

Estrogen receptor testing and 10-year mortality from breast cancer: A model for determining testing strategy.

J Pathol Inform. 2012;3:19. doi: 10.4103/2153-3539.95452. Epub 2012 Apr 28.

Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family.

BMC Med Genomics. 2009 Sep 11;2:59. doi: 10.1186/1755-8794-2-59.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验